Skip navigation
Skip navigation

Cancer rates are increasing at such a rate that research shows 42% of people who die in this country will have had a cancer diagnosis. And for most of them (64%), it is cancer which causes their death.*

The number of people living with cancer has also increased in the UK by 35% in the last ten years from 1.5 to two million in 2008**. This is due to more people getting cancer and, as treatment improves, people are surviving longer with cancer.

But whilst people are certainly living longer than ever with cancer, they are not necessarily living well.

New data from a Macmillan Cancer Supportstudyshows many have on-going, long term health problems.

The study shows that of those colorectal cancer patients still alive between five and seven years after their diagnosis***:

- Two thirds (64%) will have an on-going health problem.
- A fifth (22%) will have advanced cancers ****.
- Going on half (42%) will be living with on-going health problems like cardio vascular and intestinal illnesses

Ciarán Devane, Chief Executive of Macmillan Cancer Support said: "It is really alarming that the number of people who will get cancer is now well past one in three and that there are so many more people with cancer today than even ten years ago. The NHS really needs to recognise this long term impact and adapt their services to reflect this.

"There are currently two million people living with cancer in the UK and that number is doubling to four million over the next twenty years*****. Yet no one thinks the country can afford to double its spending on cancer. We’ve therefore got to become twice as effective in how we spend that money.

"We have a massive challenge ahead if we are to keep up with the relentless toll cancer takes on people's health, and the NHS must rise to it."

Notes to Editors:
* Macmillan estimate based on Maddams J, et al. Cancer prevalence in the United Kingdom: estimates for 2008. British Journal of Cancer. 2009. 101: 541-547; Office for National Statistics; Information Services Division (ISD) Scotland; General Register Office for Scotland; Welsh Cancer Intelligence & Surveillance Unit; Northern Ireland Cancer Registry; Northern Ireland Statistics and Research Agency.
** Macmillan estimate based on extrapolation of prevalence data from 1992 and 2008. Forman D, et al. Cancer prevalence in the UK: results from the EUROPREVAL Study. Annals of Oncology. 2003. 14: 648–654; Maddams J, et al. Cancer prevalence in the United Kingdom: estimates for 2008. British Journal of Cancer. 2009. 101: 541-547. (Estimate assumes any increase is consistent across each nation in the UK and remains unchanged over the period)
*** Wells J., et al. Using clinical attendance patterns to determine likely survivorship journey in England. NCIN Conference 2011. Data analysis is provisional and subject to clinical validation. Data are for patients in England with a diagnosis of colorectal cancer in quarter 2 2001, followed up to the end of 2007. A sample of nearly 6,000 people were taken from the National Cancer Data Repository (NCDR).
**** These data relate to health problems as identified by NHS inpatient hospital activity. Through the NCDR patients' registry data are linked to NHS inpatient hospital activity data to ascertain if patients are admitted to hospital and for what condition. Data analysis is provisional and subject to clinical validation.
***** Macmillan estimate taken from and based on Maddams J, et al. Cancer prevalence in the United Kingdom: estimates for 2008. British Journal of Cancer. 2009. 101: 541-547

About Macmillan Cancer Support:
Macmillan Cancer Support improves the lives of people affected by cancer, providing practical, medical, emotional and financial cancer support as well as cancer information on breast cancer, skin cancer and all other forms of the disease. Please visit Macmillan Cancer Support for further details.

PR Contact:
Andrea Shufflebotham
PR & Media Officer
Macmillan Cancer Support
89 Albert Embankment
London
SE1 7UQ
020 7840 4689
www.macmillan.org.uk

This press release was distributed by ResponseSource Press Release Wire on behalf of pr-sending-enterprises in the following categories: Health, for more information visit https://pressreleasewire.responsesource.com/about.